SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis

Author:

Zhang Ruyang123,Lai Linjing1,Dong Xuesi14,He Jieyu1,You Dongfang1,Chen Chao1,Lin Lijuan1,Zhu Ying1,Huang Hui1,Shen Sipeng123ORCID,Wei Liangmin1,Chen Xin1,Guo Yichen25,Liu Liya6,Su Li23,Shafer Andrea7,Moran Sebastian8,Fleischer Thomas9ORCID,Bjaanæs Maria Moksnes9,Karlsson Anna10,Planck Maria10,Staaf Johan10,Helland Åslaug911,Esteller Manel8,Wei Yongyue123,Chen Feng1312,Christiani David C.237

Affiliation:

1. Department of Biostatistics Center for Global Health School of Public Health Nanjing Medical University China

2. Department of Environmental Health Harvard T.H. Chan School of Public Health Boston MA USA

3. China International Cooperation Center for Environment and Human Health Nanjing Medical University China

4. Department of Epidemiology and Biostatistics School of Public Health Southeast University Nanjing China

5. Department of Biostatistics Harvard T.H. Chan School of Public Health Boston MA USA

6. Department of Preventive Medicine Medical School of Ningbo University China

7. Pulmonary and Critical Care Division Department of Medicine Massachusetts General Hospital Harvard Medical School Boston MAUSA

8. Bellvitge Biomedical Research Institute Institucio Catalana de Recerca i Estudis Avançats University of Barcelona Barcelona Spain

9. Department of Cancer Genetics Institute for Cancer Research Oslo University Hospital Norway

10. Division of Oncology and Pathology Department of Clinical Sciences Lund CREATE Health Strategic Center for Translational Cancer Research Lund University Sweden

11. Institute of Clinical Medicine University of Oslo Norway

12. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment Cancer Center Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Medical University China

Funder

China Postdoctoral Science Foundation

National Institutes of Health

National Natural Science Foundation of China

Nanjing Medical University

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3